Showing results (221-230 of 313) with videos related to

Sort By:
Pageof 32
Atherosclerosis|September 28, 2016
Atrial fibrillation is associated with an increased risk of myocardial infarction: Insights from a meta-analysisXue-Yuan Guo, Na Li, Xin Du, et al.
The American Journal of Cardiology|December 2, 2019
Dabigatran Persistence and Outcomes Following Discontinuation in Atrial Fibrillation Patients from the GLORIA-AF RegistryMiney Paquette, Lionel Riou França, Christine Teutsch, et al.
Archives of Cardiovascular Diseases|February 21, 2025
Percutaneous coronary intervention in patients with acute coronary syndromes and increased platelet countYang Zhang, Yongchen Hao, Jun Liu, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 21, 2007
Catheter ablation of atrial fibrillation in patients with hyperthyroidismChang Sheng Ma, Xu Liu, Fu Li Hu, et al.
Pacing and Clinical Electrophysiology : PACE|September 16, 2022
Repeat ablation strategy for recurrent persistent atrial fibrillation: A propensity-matched score comparison between "2C3L" and "extensive ablation" approachJing Lin, Chen-Xi Jiang, De-Yong Long, et al.
American Heart Journal|December 7, 2019
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry programMichał Mazurek, Christine Teutsch, Hans-Christoph Diener, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|February 10, 2021
Anticoagulation Prescription and Outcomes in Relation to Renal Function in Patients with Atrial Fibrillation: Results from GLORIA-AFSake J van der Wall, Christine Teutsch, Sergio J Dubner, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 10, 2018
Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control StudyZhi-Zhao Li, Xin Du, Xue-Yuan Guo, et al.
Chinese Medical Journal|September 8, 2010
Prognostic value of baseline C-reactive protein levels in patients undergoing coronary revascularizationXu Li, Xiao-Hui Liu, Shao-Ping Nie, et al.
ESC Heart Failure|July 3, 2020
Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AFSergio J Dubner, Christine Teutsch, Menno V Huisman, et al.
Pageof 32